NFKB1 and Sepsis: miR-181a-5p down-regulation inhibited inflammatory response in vitro and in vivo through repressing NF-κB signaling pathway by targeting SIRT1, indicating the anti-inflammatory effect of miR-181a-5p inhibitor in sepsis.